[HTML][HTML] Epidemiology of sarcopenia: Prevalence, risk factors, and consequences

S Yuan, SC Larsson - Metabolism, 2023 - Elsevier
Sarcopenia is a geriatric condition featured by a progressive loss of muscle mass and
function and associated with various adverse health outcomes. In this review, we aimed to …

Metabolic dysfunction-associated steatotic liver disease (MASLD): a state-of-the-art review

WK Chan, KH Chuah, RB Rajaram… - Journal of obesity & …, 2023 - pmc.ncbi.nlm.nih.gov
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the latest term for
steatotic liver disease associated with metabolic syndrome. MASLD is the most common …

Type 2 diabetes

E Ahmad, S Lim, R Lamptey, DR Webb, MJ Davies - The Lancet, 2022 - thelancet.com
Type 2 diabetes accounts for nearly 90% of the approximately 537 million cases of diabetes
worldwide. The number affected is increasing rapidly with alarming trends in children and …

World guidelines for falls prevention and management for older adults: a global initiative

M Montero-Odasso, N Van Der Velde, FC Martin… - Age and …, 2022 - academic.oup.com
Background falls and fall-related injuries are common in older adults, have negative effects
on functional independence and quality of life and are associated with increased morbidity …

The conceptual definition of sarcopenia: Delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS)

B Kirk, PM Cawthon, H Arai, JA Ávila-Funes… - Age and …, 2024 - academic.oup.com
Importance Sarcopenia, the age-related loss of muscle mass and strength/function, is an
important clinical condition. However, no international consensus on the definition exists …

Sarcopenia and cardiovascular diseases

AA Damluji, M Alfaraidhy, N AlHajri, NN Rohant… - Circulation, 2023 - ahajournals.org
Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …

Sarcopenia definition, diagnosis and treatment: consensus is growing

AA Sayer, A Cruz-Jentoft - Age and ageing, 2022 - academic.oup.com
Sarcopenia is a skeletal muscle disorder that commonly occurs with advancing age as well
as with a number of long-term conditions. Recognition in clinical practice is relatively recent …

The landscape of aging

Y Cai, W Song, J Li, Y **g, C Liang, L Zhang… - Science China Life …, 2022 - Springer
Aging is characterized by a progressive deterioration of physiological integrity, leading to
impaired functional ability and ultimately increased susceptibility to death. It is a major risk …

[HTML][HTML] Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement

LM Donini, L Busetto, SC Bischoff, T Cederholm… - Obesity facts, 2022 - karger.com
Introduction: Loss of skeletal muscle mass and function (sarcopenia) is common in
individuals with obesity due to metabolic changes associated with a sedentary lifestyle …

Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis

F Petermann‐Rocha, V Balntzi, SR Gray… - Journal of cachexia …, 2022 - Wiley Online Library
Background Sarcopenia is defined as the loss of muscle mass and strength. Despite the
seriousness of this disease, a single diagnostic criterion has not yet been established. Few …